A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong(Cell Technology (China)), Fangfang Zhou(Soochow University)
Cited by 560
Related Papers
SARS-CoV-2 Omicron variant: recent progress and future perspectives
|Signal Transduction and Targeted Therapy|2022|631
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
|Advanced Science|2019|333
The function and clinical application of extracellular vesicles in innate immune regulation
|Cellular and Molecular Immunology|2020|292
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
|Nature Communications|2014|180